HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of and risk factors for equine glandular and squamous gastric disease in polo horses.

Abstract
The objectives of this study were to determine the prevalence rates and risk factors for equine glandular gastric disease (EGGD) and equine squamous gastric disease (ESGD) in a population of 63 polo horses in competition. The prevalence of EGGD grade ≥ 1 was 69% and EGGD ≥ 2 was 31%. The prevalence of ESGD grade ≥ 1 was 54% and grade ≥ 2 was 37%. The risk factors retained in the final multivariable models were years of experience in polo competition for EGGD grade ≥ 1 and for grade ≥ 2, with decreased experience being associated with EGGD and weekly exercise duration and non-steroidal anti-inflammatory drug (NSAID) use being associated with ESGD grade ≥ 1. Decreasing weekly exercise duration was the only risk factor associated with ESGD grade ≥ 2. Equine gastric disease was common in this population of polo horses and the amount of experience and weekly exercise duration were related to the risk of disease.
AuthorsHeidi E Banse, Heath MacLeod, Candice Crosby, M Claire Windeyer
JournalThe Canadian veterinary journal = La revue veterinaire canadienne (Can Vet J) Vol. 59 Issue 8 Pg. 880-884 (08 2018) ISSN: 0008-5286 [Print] Canada
PMID30104780 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
Topics
  • Alberta
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (adverse effects, therapeutic use)
  • Female
  • Gastroscopy (veterinary)
  • Horse Diseases (epidemiology, etiology)
  • Horses
  • Male
  • Physical Conditioning, Animal (statistics & numerical data)
  • Prevalence
  • Risk Factors
  • Stomach Diseases (epidemiology, etiology, veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: